APA (7th ed.) Citation

C, V., B, G., F, G., P, C., C, F., C, R., . . . F, G. (2025). Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia. Blood cancer journal, 15(1), 181. https://doi.org/10.1038/s41408-025-01394-7

Chicago Style (17th ed.) Citation

C, Vetro, et al. "Real-world Multicenter Analysis of CPX-351 Efficacy in Patients Aged Less than 60 Years with Secondary Acute Myeloid Leukemia." Blood Cancer Journal 15, no. 1 (2025): 181. https://doi.org/10.1038/s41408-025-01394-7.

MLA (9th ed.) Citation

C, Vetro, et al. "Real-world Multicenter Analysis of CPX-351 Efficacy in Patients Aged Less than 60 Years with Secondary Acute Myeloid Leukemia." Blood Cancer Journal, vol. 15, no. 1, 2025, p. 181, https://doi.org/10.1038/s41408-025-01394-7.